SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001288123-09-000032
Filing Date
2009-06-15
Accepted
2009-06-15 10:59:00
Documents
1
Period of Report
2009-06-11

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 1436
  Complete submission text file 0001288123-09-000032.txt   3182
Mailing Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010
Business Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010 212-994-8200
ANTIGENICS INC /DE/ (Issuer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 127 STEPHEN MATHER RD DARIEN CT 06845
Business Address
MARGARET EISEN (Reporting) CIK: 0001222010 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-29089 | Film No.: 09891205